Radiotherapy vs sequential pegaspargase, gemcitabine, cisplatin and dexamethasone and radiotherapy in newly diagnosed early natural killer/T‐cell lymphoma: A randomized, controlled, open‐label, multicenter study
Lei Zhang(First Affiliated Hospital of Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Xiaolong Wu(First Affiliated Hospital of Zhengzhou University), Guannan Wang(First Affiliated Hospital of Zhengzhou University), Yan Wang(Fujian Normal University), Xinhua Wang(Zhengzhou University), Xin Li(Harbin Medical University), Jingjing Wu(Beijing Tian Tan Hospital), Jiaqin Yan(First Affiliated Hospital of Zhengzhou University), Zhenchang Sun(First Affiliated Hospital of Zhengzhou University), Hui Yu(First Affiliated Hospital of Zhengzhou University), Xiaorui Fu(First Affiliated Hospital of Zhengzhou University), Yu Chang(Jilin University), Xudong Zhang(First Affiliated Hospital of Zhengzhou University), Feifei Nan(First Affiliated Hospital of Zhengzhou University), Zhi‐Yuan Zhou(Tsinghua University), Ling Li(First Affiliated Hospital of Zhengzhou University), Wencai Li(First Affiliated Hospital of Zhengzhou University)
Cited by 16
Related Papers
The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
|Drug Design Development and Therapy|2021|377
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
|Cancer Cell|2018|251
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study
|The Lancet Infectious Diseases|2015|231